Clairvoyant Therapeutics has closed its $3 million plus seed round financing with bulk of the investment coming from four institutional investors including Iter Investments, Negev Capital, and Ambria Capital. Vancouver… Read More
McEwen Stem Cell Institute at the University Health Network (UHN) is a global leader in stem cell research and regenerative medicine VANCOUVER, BC – Aspect Biosystems, a biotechnology company pioneering… Read More
Transformative AI System Enhances Colorectal Cancer Detection Capabilities BRAMPTON, ON – Medtronic Canada ULC, a subsidiary of Medtronic plc (NYSE: MDT) — the global leader in medical technology — announced it… Read More
GSK today announced that Phil Dormitzer M.D., Ph.D., will join the company as Global Head of Vaccines R&D on 3 December 2021. Phil will report to Dr Hal Barron, Chief Scientific Officer… Read More
The first peer-reviewed study in North America examining dosing intervals for COVID-19 mRNA vaccines shows a delayed second dose leads to a stronger immune response. CHÉOS Scientist and principal investigator… Read More
